DONALD MAHONEY, JR. to Remission Induction
This is a "connection" page, showing publications DONALD MAHONEY, JR. has written about Remission Induction.
Connection Strength
0.123
-
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. J Clin Oncol. 1998 May; 16(5):1712-22.
Score: 0.035
-
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J Clin Oncol. 1998 Jan; 16(1):246-54.
Score: 0.034
-
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1995 May 15; 75(10):2623-31.
Score: 0.028
-
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 1998 Aug; 16(8):2854-63.
Score: 0.009
-
Recombinant interferon alfa-2b therapy in children with immune thrombocytopenic purpura. Pediatr Hematol Oncol. 1993 Jul-Sep; 10(3):293-6.
Score: 0.006
-
Hodgkin's disease associated with central pontine myelinolysis. Med Pediatr Oncol. 1993; 21(4):311-4.
Score: 0.006
-
Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neurooncol. 1992 Sep; 14(1):57-62.
Score: 0.006